Myrbetriq (mirabegron)

pCPA File Number: 20837

Negotiation Status:

Concluded with an LOI

Indication(s):

Overactive Bladder

Sponsor/Manufacturer:

Astellas Pharma Inc.

CADTH Project Number:

SR0363

pCPA Engagement Letter Issued:

2015-01-14

Negotiation Process Concluded:

2015-04-08